Tirzepatide is the newer, more powerful option, a dual-action GLP-1/GIP receptor agonist that produces weight loss numbers researchers have never seen from any other medication
4 Well continue to post updates as they occur
Compounded GLP-1 medicines such as Semaglutide and Tirzepatide are created in a state board of pharmacy licensed and Drug Enforcement Administration (DEA) registered sterile compounding pharmacies
For combination and stacking questions, read our guide on whether researchers can take retatrutide and semaglutide together
At Shapiro Legal Group, PLLC, we take Ozempic, Wegovy, Rybelsus, Mounjaro, and Trulicity claims on a contingency fee basis
The SURPASS-CVOT trial is a phase 3, randomized, double-blind cardiovascular outcomes trial that will assess tirzepatide for both non-inferiority and superiority against dulaglutide. For dulaglutide, this effect is already proven: According to the Trulicity website, the drug may be used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. How do I know which medication is right for me
